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ORIGINAL ARTICLE
Cardiovascular disease risk factors in Pakistani population with newly
diagnosed Type 2 diabetes mellitus: A cross-sectional study of selected family
practitioner clinics in four provinces of Pakistan (CardiP Study)
Syed Abbas Raza,1 Mariam Hassan,2 Farhana Badar,3 Farah Rasheed,4 Fouzia Meerza,5 Sumeyya Azam,6 Ali Jawa,7 Imtiaz Hassan,8
Faisal Masood Qureshi,9 Zakir Alvi,10 Saeed Ahmed Mahar,11 Azizul Hasan Aamir,12 Rauf Niazi,13 Najmul Islam14

Abstract
Objective: To explore cardiovascular risk factors in people with newly-diagnosed type 2 diabetes mellitus.
Methods: The cross-sectional, prospective, multicentre, study was conducted from June 2014 till July 2015 at family
practice clinics in 27 cities across Pakistan, and comprised individuals aged 30-50 years diagnosed with type 2
diabetes mellitus within the preceding six months. Laboratory investigations were conducted at Shaukat Khanum
Memorial Cancer Hospital and Research Centre, Lahore, and Aga Khan University Hospital, Karachi. The 10-year
absolute risk of fatal or non-fatal coronary heart disease and stroke was calculated using the United Kingdom
Prospective Diabetes Study Risk Engine version 2.0. Data were analysed using SPSS 19.
Results: Out of 888 subjects, 362(40.8%) were women and 526(59.2%) were men. The overall mean presenting age
was 42.4±5.8 years. After stratification by age, those ≥40 years were significantly associated with higher glycated
haemoglobin (p=0.02) and those ≤39 years were associated with higher levels of very low density lipoprotein
(p=0.001) and triglyceride (p=0.006). The mean risk estimate for CHD was 9.7% (95% Confidence Interval (CI) 9.010.1)), for fatal CHD 4.4% (95% CI 4.0-4.6), for stroke 1.5% (95% CI 1.2-1.7), and for fatal stroke 0.25% (95% CI 0.240.26).
Conclusion: There is a need for screening cardiovascular risk factors even in younger age groups of newlydiagnosed diabetes.
Keywords: Type 2 diabetes mellitus, Cardiovascular disease, Dyslipidaemia, Risk factors. (JPMA 69: 306; 2019)

Introduction
Diabetes is a metabolic disorder with an increasing global
prevalence largely due to population expansion, aging,
urbanisation, increasing obesity and sedentary lifestyle.1
According to International Diabetes Federation (IDF)
estimates, worldwide the number of people with type 2
diabetes mellitus (T2DM) was 387 million in 2014 with a
projected rise to 592 million in 2035.2 The greatest
proportional increase in adults with diabetes is expected
in low-income and lower middle-income countries
(LMICs).3 In 2007, more than 110 million people in Asia
were living with diabetes, with a very high disease load
among the young. Young age of onset and long disease
duration puts Asian people with diabetes at high risk for
cardio-renal complications. Cardiovascular disease (CVD)
is a serious complication of T2DM that results in
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substantial morbidity, increased mortality and burden on
healthcare infrastructure.4
The greater morbidity and mortality from CVD in
developing countries will have the greatest impact in
South Asia, which forms nearly a quarter of the total
global population and where a serious lack of access to
healthcare also exists.
Pakistan, an LMIC with a total population of
approximately 199 million projected population based on
census figures, has an estimated diabetes prevalence of
11.4% in the age group of 25 years and above.5
Few studies from Pakistan have explored the chronic
complications of diabetes, including CVD.5,6 However, no
nationwide data exists on cardiovascular complications of
diabetes. Risk factors for CVD, such as poor glycaemic
control, smoking, hypertension (HTN) and deranged lipid
profile, are amenable to intervention which could reduce
the risk of complications.
At present, globally the vast majority of people with
diabetes receive frontline treatment by general
practitioners (GPs) and family physicians (FPs) rather than
by specialist endocrinologists.7 The current study was

307

S. A. Raza, M. Hassan, F. Badar, et al

planned to explore risk factors for cardiovascular
complications of diabetes in people presenting to GP/FP
clinics across Pakistan. The primary objective was to
determine the frequency and distribution of the fixed
(age, gender, ethnicity) and modifiable risk factors
(glycated haemoglobin [HbA1c] levels, blood pressure
(BP), lipid profile and smoking status) that contribute to
CVD risk among diabetics. The secondary objective
included assessment of absolute risk of a CVD event over
the next 10 years using current values for all the fixed risk
factors, and potentially modifiable risk factors like HbA1c
levels, systolic blood pressure (SBP), high-density
lipoprotein cholesterol [HDL-C] levels, and smoking
status, using UK prospective diabetes study (UKPDS) risk
calculator for CVD risk estimation.8 This will hopefully fill
the gaps in knowledge that can form the basis for
effective national prevention programmes targeting this
population.

Subjects and Methods
The cross-sectional, prospective, multicentre, study was
conducted from June 2014 till July 2015 at family practice
clinics in 27 cities across Pakistan, and comprised
individuals aged 30-50 years diagnosed with T2DM in the
preceding six months.
Those matching the inclusion criterion consecutively
presenting at the outpatient clinics of the participating
centres were screened for the study. Those aged under 30
years were excluded due to the likelihood of type 1 DM,
while those aged above 50 years were excluded as age is
an independent risk factor for CVD and could act as a
confounder. The eligible participants were enrolled after
written informed consent. The study was approved by the
institutional review board of the coordinating centre,
Shaukat Khanum Memorial Cancer Hospital and Research
Centre (SKMCH&RC), Lahore, and the National Bioethics
Committee (NBC), Islamabad, Pakistan.
Endocrinologists as Regional investigators (RIs) were
included and they were part of the study steering
committee that comprised RIs, Principal investigator (PI)
and co-PIs and was responsible for the study
questionnaire, design and oversight. Larger 'sample' of
centres from larger cities was selected to ensure adequate
representation but it was convenience-based selection as
per ease of access. We enrolled a selected number of 5
participants from each clinic. All the participating GPs
received training on protocol procedures prior to the
initiation to ensure protocol compliance and uniformity in
patient selection and data collection across all centres.
The study questionnaire included the eligibility checklist
and study variables such as demographic information,

date of diabetes diagnosis, height, weight, BP
measurement, smoking and family history etc. Data on
laboratory variables was collected directly from lab
reports. Lab investigations were carried out at SKMCH&RC
and Aga Khan University Hospital (AKUH), Karachi.
Fasting blood sample with minimum 10-hour fasting was
collected. Two individuals did the study oversight for data
queries resolution and data validation at the coordinating
centre for quality control.
With an expected proportion of diabetics with high
cholesterol level being 46%, we aimed for a 95%
confidence interval (CI) with a sample size of 1000
participants. Keeping into account 30% expected missing
data, the target sample was kept at 1300.
Demographic and baseline characteristics were
expressed using descriptive statistics. Lab variables to
normal ranges, as defined by the American Diabetes
Association (ADA) criteria9 for fasting glucose, HbA1c and
lipid profile, were compared. Joint National Committee
(JNC) criteria were used to define HTN and for
categorisation of BP readings.10,11 Ethnicity specific cutoffs were used for body mass index (BMI).12 Data was
analysed using SPSS 19.
The 10-year absolute risk of fatal or non-fatal coronary
heart disease (CHD) and stroke was calculated using
the UKPDS risk engine version 2.0 which is a T2DMspecific risk calculator based on 53,000 patients' years
of data.8

Results
Of the 1067 participants enrolled, 888(83.2%) comprised
the study sample. Of them, 362(40.8%) were women and
526(59.2%) were men.
In terms of age bifurcation, 612(69%) subjects were ≥40
years and 276(31.1%) were <39 years. Province-wise,
534(60.1%), 253(28.5%), 91(10.2%) and, 10(1.1%) were
residents of Punjab, Sindh, KPK and Balochistan,
respectively. The vast majority of participants were from
the city of Karachi 114(12.8%) and Lahore 106(11.9%),
followed by Faisalabad 56(6.3%), Multan 56(6.3%),
Peshawar 54(6.1%), Hyderabad 54( 6.1%), Bahawalpur
52(5.9%), Rawalpindi 46(5.2%), Sukkur 37(4.2%),
Gujranwala 36(4.1%), Larkana 34(3.8%), Sahiwal-Okara
27(3.0%), Gujrat 25(2.8%), Rahim Yar Khan 22(2.5%),
Sargodha 20(2.3%), Abbottabad 19(2.1%), Sialkot
19(2.1%), Jhang 17(1.9%), Sheikhupura 15(1.7%),
Bhakkar & Mianwali 15(1.7%), Mardan 13(1.5%),
Islamabad 11(1.2%), Bannu-D I Khan 11(1.2%), Quetta
10(1.1%), Nawabshah 9(1.0%), Toba Tek Singh 5( 0.6%),
and Khairpur 5(0.6%).
J Pak Med Assoc
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Table-2: Frequency and Distribution of modifiable risk factors as per sub-categories.

Table-1: Characteristics of participants.
Characteristic
Age - Mean (Years)
<39 Years, n (%)
>40 years, n (%)
Gender
Male, n (%)
Female, n (%)
Ethnicity, n (%)
Punjabi
Sindhi
Saraiki
Balochi
Pathan
Kashmiri
Urdu Speaking
Mixed/Multiracial
Family history of Type 2 DM, n (%)
Yes
No
Family history of Ischaemic Heart Disease (IHD),
n (%)
Yes
No
Family history of Hypertension, n (%)
Yes
No
Family history of Other Diseases, n (%)
Yes
No
Other - Stroke
Other - CVA
Other - Not Mentioned
Other - Chronic Severe Asthma

n=888
42.42 ± 5.8
276 (31.1%)
612 (68.9%)
526 (59.2%)
362 (40.8%)
431 (48.5%)
74 (8.3%)
81 (9.1%)
6 (0.7%)
97 (10.9%)
12 (1.4%)
170 (19.1%)
17 (1.9%)
645 (72.6%)
243 (27.4%)

222 (25%)
666 (75%)
363 (40.9%)
525 (59.1%)
3 (0.3%)
836 (94.1%)
8 (0.9%)
4 (0.5%)
35 (3.9%)
2 (0.2%)

Data are expressed as mean ± standard deviation or number (percentage).
DM: Diabetes mellitus.
CVA: Cerebrovascular accident.

As regards ethnicity, 431(48.5%) participants were
Punjabi, followed by 170(19%) Urdu-speaking, 97(11%)
Pathan, 81(9%) Saraiki, 74(8.3%) Sindhi, 17(2%)
mixed/multiracial, 12(1.4%) Kashmiri and 6(0.7%) Balochi
(Table-1).
The overall mean presenting age of participants was
42.4±5.8 years; mean weight was 76±14.1kg; height
1.7±0.01
meters;
BMI
27.8±5.1kg/m2;
SBP
128.1±14.8mmHg; diastolic blood pressure (DBP)
84.2±9.3mmHg; blood glucose 175.5±83.5mg/dl; HbA1C
80±6mmol/mol
(9.5±2.7%);
triglyceride
(TG)
201.6±146.3mg/dl; serum total cholesterol (TC)
186.2±45.0mg/dl; VLDL 40.4±29.3mg/dl; low-density
lipoprotein cholesterol (LDL-C) 115.7±36.0mg/dl; HDL-C
41.2±11.2mg/dl.
Vol. 69, No. 3, March 2019

Characteristics

Categories

Body Mass Index (BMI)

Frequency
Distribution, n (%)

Under Weight (<18.0 kg/m2)
Normal BMI (18.0 - 22.9 kg/m2)
Over Weight (23 - 24.9 kg/m2)
Obesity (>25 kg/m2)
Blood Pressure
Normal BP: (< 120/80)
Pre-hypertension: (SBP 120-139 by DBP 8089)
SBP <140 by DBP >90
SBP >140 by DBP <90
High BP >140 by >90
Fasting Glucose Level
Normal (<99mg/dL)
Impaired fasting Glucose
(100 - 125 mg/dL)
Abnormal (>126 mg/dL)
Glycated haemoglobin
<39mmol/mol (<5.7%)
(HbA1c)
39-46mmol/mol (5.7 - 6.4%)
>48mmol/mol (>6.5%)
Total Cholesterol
Within Normal Range (<200mg/dL)
Above Normal Range (200->240mg/dL)
LDL Cholesterol
Within Normal Range (<100mg/dL)
Above Normal Range (>100mg/dL)
HDL Cholesterol
Below Normal (<40mg/dL)
Within Normal Range (40-59mg/dL)
Above Normal Range (>60mg/dL)
VLDL
Within Normal Range (2-30mg/dL)
Above Normal Range (>30mg/dL)
Triglycerides
Within Normal Range (<150mg/dL)
Above Normal Range (150->200mg/dL)

10 (1.1%)
137 (15.4%)
120 (13.5%)
621 (69.9%)
357 (40.2%)
192 (21.6%)
122 (13.7%)
39 (4.4%)
178 (20.0%)
153 (17.2%)
150 (16.9%)
585 (65.9%)
57 (6.4%)
81 (9.1%)
750 (84.5%)
570 (64.2%)
318 (35.8%)
488 (55.0%)
400 (45%)
309 (34.8%)
565 (63.6%)
14 (1.6%)
498 (56.1%)
390 (43.9%)
501 (56.4%)
387 (43.6%)

LDL: Low-density lipoprotein
HDL: High-density lipoprotein
VLDL: Very low-density lipoprotein.

The commonest sub-group for each of the categorical
variables under consideration included having a family
history of diabetes 645(72.6%); not having a family history
of hypertension 525(59.1%); not having a family history of
ischaemic heart disease (IHD) 666(75%); not having a
family history of other diseases 836(94.1%); never having
smoked 750(84.5%); being obese 621(69.9%); not having
had atrial fibrillation 594(97.4%); having normal BP
357(40.2%); having abnormal blood glucose 585(65.9%);
having HbA1c levels 6.5% or higher 750(84.5%); having
TG levels within normal range 501(56.4%); having TC
levels within normal range 570(64.2%); having VLDL levels
within normal range 498(56.1%); having LDL-C levels
within normal range 488(55%); and having HDL-C levels
within normal range 565(63.6%). In addition to 621(70%)
obese subjects, another 120(13.5%) were overweight.
Among the 531(60%) with abnormal BP, 192(21.6%) were
pre-hypertensive, 39(4.4%) had isolated systolic
hypertension, 122(13.7%) had isolated diastolic
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Table-3: Proportional distribution of sub-categories of risk factors associated with cardiovascular disease, by age-group (N=888).

Risk factor
Gender
Male
Female
Family history of Type 2 diabetes
Yes
No
IHD
Yes
No
Hypertension
Yes
No
Other diseases
Yes
No
Smoking status
Current
Past
Never
BMI (kg/m2)
Under weight (<18.0)
Normal BMI (18.0-22.9)
Over weight (23-24.9)
Obesity (>25)
Blood pressure (mmHg)
Normal BP (< 120/80)
Pre HTN (SBP 120-139 by DBP 80-89)
SBP <140 by DBP >90
SBP >140 by DBP <90
High BP >140 by >90
Atrial fibrillation
Yes
No
Fasting blood glucose level (mg/dL)
Normal (<99)
Impaired fasting glucose (100-125)
Abnormal (>126)
Glycated haemoglobin/HbA1c (%)
<39 mmol/mol (<5.7)
39-46 mmol/mol (5.7-6.4)
>48 mmol/mol (>6.5)
Fasting total cholesterol (mg/dL)
Normal (<200)
Above normal (200 to >240)
LDL-C (mg/dL)
Within normal (100-129)
Above normal (130 to >159)
HDL-C (mg/dL)
Below normal (<40)
Normal (40-59)
Above normal (>60)
VLDL (mg/dL)
Within normal (2-30)
Above normal (>30)
Triglycerides (mg/dL)
Normal (<150)
Above normal (150 to >200)

< 39 years (n=276) Count (%)

Age-category
> 40 years (n=612) Count (%)

174 (63)
102 (37)

352 (57.5)
260 (42.5)

212 (76.8)
64 (23.2)

433 (70.8)
179 (29.2)

73 (26.4)
203 (73.6)

149 (24.3)
463 (75.7)

123 (44.6)
153 (55.4)

240 (39.2)
372 (60.8)

13 (4.7)
263 (95.8)

39 (6.4)
573 (93.6)

33 (12.0)
9 (3.3)
234 (84.8)

64 (10.5)
32 (5.2)
516 (84.3)

4 (1.4)
43 (15.6)
31 (11.2)
198 (71.7)

6 (1.0)
94 (15.4)
89 (14.5)
423 (69.1)

126 (45.7)
56 (20.3)
42 (15.2)
8 (2.9)
44 (15.9)

231 (37.7)
136 (22.2)
80 (13.1)
31 (5.1)
134 (21.9)

5 (1.8)
271 (98.2)

18 (2.9)
594 (97.4)

46 (16.7)
39 (14.1)
191 (69.2)

107 (17.5)
111 (18.1)
394 (64.4)

26 (9.4)
19 (6.9)
231 (83.7)

31 (5.1)
62 (10.1)
519 (84.8)

171 (62.0)
105 (38.0)

399 (65.2)
213 (34.8)

145 (52.5)
131 (47.5)

343 (56.0)
269 (44.0)

109 (39.5)
162 (58.7)
5 (1.8)

200 (32.7)
403 (65.8)
9 (1.5)

133 (48.2)
143 (51.8)

365 (59.6)
247 (40.4)

137 (49.6)
139 (50.4)

364 (59.5)
248 (40.5)

χ2 test, (df), & p-value
2.4, (1), 0.12
3.5, (1), 0.06
0.4, (1), 0.50
2.2, (1), 0.13
0.9, (1), 0.32
1.9, (2), 0.36

2.1, (3), 0.55

9.3, (4), 0.054

0.9, (1), 0.32
2.5, (2), 0.27

†7.8, (2), 0.02

0.8, (1), 0.35
0.9, (1), 0.33
4.2, (2), 0.12

†10.1, (1), 0.001
†7.4, (1), 0.006

IHD: Ischaemic Heart Disease. BMI: Body mass index. HTN: Hypertension. SBP: Systolic blood pressure. DBP: Diastolic blood pressure. LDL: Low-density lipoprotein. HDL: High-density lipoprotein.
VLDL: Very low-density lipoprotein.
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developing complications of
diabetes due to longer
hyperglycaemic exposure.16
Participants belonging to
Punjabi ethnicity were more
common in our study perhaps
due to a large number of cities
included from the province of
Punjab which is the most
populated province of the
country.17

Figure: Mean ten-year risk estimates for cardiovascular disease as assessed by UKPDS risk calculator.
Lines represent mean risk for non-fatal and fatal coronary heart disease (CHD), fatal coronary heart disease (fatal CHD), non-fatal
and fatal stroke (stroke) and fatal stroke. Confidence intervals are shown as error bars.

hypertension and 178(20%) had hypertension.
Analyses of blood glucose levels and HbA1c were also
done (Table-2).
Those aged >40 years were significantly associated with
higher HbA1c (p=0.02) and those aged <39 years were
significantly associated with higher levels of VLDL
(p=0.001) and TG (p=0.006). Other associations were not
statistically significant (Table-3).
Mean risk estimate for CHD was 9.7% (CI: 9.0-10.1), fatal
CHD 4.4% (CI: 4.0-4.6), stroke 1.5% (CI: 1.2-1.7), and fatal
stroke 0.25% (CI: 0.22-0.24) (Figure).

Discussion
Diabetes adds to the CVD risk, and the National
Cholesterol Education Programme (NCEP) categorises
diabetes as CVD equivalent.13 Most of the cardiovascular
risk factors like dyslipidaemia, hypertension, obesity and
glucose intolerance co-exist in people with T2DM which
increases their risk of CVD.14
Number of men in our study was more compared to the
number of women. Number of participants in age group
40-49 years was more compared to those younger than
40 years. A younger age of onset is seen in a developing
country15 which puts this population at a higher risk of
Vol. 69, No. 3, March 2019

Familial clustering of T2DM is
well-known and is high in
South Asians.18 Similarly, in our
study almost two-thirds of the
participants had family history
for diabetes in first-degree
relatives. Family history of IHD
in first-degree relatives is also a
risk factor for the development
of IHD or CVD.19 In our study
25% participants had a family
history of IHD.

Smoking is a strong risk factor
for developing CVD, especially
amongst people with diabetes.20 The prevalence of
smoking in our study was lower (15%) and similar to
earlier studies done in Pakistan16,20 which indicates a
reporting bias.
The mean BMI of our study population was 27.76 kg/m2,
which does not fulfil obesity criteria from the developed
world (>30kg/m2).21 Studies suggest that for a given BMI,
South Asians have more visceral fat than Western
population which increases metabolic risk associated
with obesity.22 When we used ethnicity-specific criteria11
to define obesity (BMI>25kg/m2), we found 70% obese
patients in the study. South Asians are considered to be at
risk of developing obesity-related co-morbidities at lower
levels of BMI and waist circumference.11 The higher
prevalence of obesity may probably be one of the reasons
for the study population developing diabetes at an early
age. The findings of the current study are consistent with
another cross-sectional study from Karachi which
reported 68% prevalence of obesity.16 A nationwide study
from India involving 4600 newly-diagnosed T2DM people
reported 26% prevalence of obesity.23
Mean HbA1C was 80±6mmol/mol (9.5 ± 2.71%) in the
present study. Though only participants with confirmed
T2DM diagnosis were included, 6% participants had an
HbA1c <5.7% and another 9% had HbA1c in the pre-
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diabetes range of 5.7-6.4%. Considering that participants
enrolled were recently diagnosed with T2DM, it is quite
likely an effect of lifestyle modification resulting in a
better glycaemic control in some participants, or it was
too early for HbA1C to have started rising. HbA1C
compared in two-sub groups (A: 30-39 years; B: 40-49
years) revealed higher HbA1C in group B, and this
difference was statistically significant. This represents
poor long-term control of blood sugar or possible delay in
diagnoses. Fasting blood glucose is altered in people with
diabetes, but in the present study, 17.2% had normal
fasting glucose, 16.9% and 65.9% had impaired and
abnormal fasting glucose, respectively. Possible
explanations are improvement in glycaemic control by
lifestyle modification or abnormalities of post-prandial
glucose levels only.
People with diabetes are more likely to have atherogenic
dyslipidaemia which is characterised by TGs, raised small
dense LDL (sdLDL), elevated VLDL and decreased HDL-C
levels.24 The current study found that >40% participants
had dyslipidaemia wherein the prevalence of elevated TC,
elevated LDL-C and VLDL were seen in 43.9%, 45% and
43.9% participants respectively. Low HDL-C was seen in
34.8% participants and 43.6% had elevated TG. It is quite
likely that some of the patients had >1 lipid abnormalities.
A higher prevalence of dyslipidaemia is an important
finding as the presence of dyslipidaemia in people with
T2DM would increase the risk of CVD by 3-4 folds
compared to people without diabetes having
dyslipidaemia.25 Furthermore, ~50% participants in the
younger age group (<39 years) had higher VLDL and TG
levels compared to the older age group (>40 years),
indicating a higher prevalence of dyslipidaemia in the
younger age group. Lower HDL-C levels and higher TG
levels were seen in South Asians compared to British
population in the UK.16
Hypertension is well- recognised as an independent risk
factor for the development of CVD. This risk increases
further when it is associated with diabetes.14 The mean
SBP and DBP was 128.08±4.76mmHg and 84.23±9.28
mmHg which was slightly higher than normal and similar
to that reported by an earlier study that reported a higher
SBP and DBP in South Asians compared to Caucasians.16
Out of all participants enrolled, 38% had hypertension,
defined as SBP >140 mmHg and/or DBP >90 mmHg. A
local study reported 42% prevalence of HTN in people
with T2DM (20). The JNC 7 guide for the management of
HTN reported that amongst those older than age 50, SBP
>140mmHg is a more significant determinant of CVD risk
than DBP. Pre-hypertension individuals (SBP 120139mmHg or DBP 80-90mmHg) should be advised on

lifestyle modification to prevent the progressive risk in BP
to decrease risk of CVD.26
The current study used the UKPDS risk engine to assess
10-year absolute risk of CVD. The strength of the engine is
that it can address multiple aspects of cardiovascular
disease risk27 with a higher applicability to high-risk
cohorts of diabetes. UKPDS risk engine is intended for use
in adults who have T2DM, no previous heart disease or
strokes, white Afro-Caribbean or Asian-Indian ethnic
background and no serious life-threatening illness such as
cancer.12 Limitations of UKPDS risk engine have been
described since the model was derived from people
recruited for a randomised controlled trial and so was
limited to people eligible for the study.28 A study among
Australian diabetics29 compared UKPDS and Framingham
cardiovascular risk equation and found UKPDS calculator
to be suitable only for stroke risk prediction in this
population alluding to need for ethnicity-specific
calculators. In comparison with QRISK2 (a cardiovascular
disease risk algorithm based on data from QRESEARCH
database), the UKPDS calculator is considered to be more
specific to patients with T2DM, highlighting that risk
estimations amongst persons with diabetes differ from
healthy individuals.30
As in any cross-sectional study, selection and recall bias
exists in the current study which is its limitation. Data on
lifestyle and educational status of the participants was not
collected, which are associated with CVD risk.
Participating centres were from 27 larger cities of Pakistan
and it may not be appropriate to generalise the findings
to the rural population. The study used conveniencebased sampling, which can impact sample
representativeness.

Conclusion
CVD and diabetes are amongst the commonest noncommunicable diseases in Pakistan associated with major
morbidity, mortality and burden on healthcare
infrastructure. To the best of our knowledge this is the
largest study to assess CVD risk amongst people with
T2DM. Data also highlights the need of screening for
cardiovascular risk factors in younger age group with
newly diagnosed T2DM. Ethnicity-specific thresholds are
needed for BMI, indicating the need for national
consensus guidelines. Public health programmes
addressing risk factors for CVD that are amenable to
intervention through lifestyle modification are needed.
Disclaimer: The study was presented at the following
meetings: Updates on Diabetes / Diabetes Quiz: During
2nd Cardiometabolic Conference: Tokyo Japan. May 17,
2017; Diabetes and Cardiovascular Risk: Finding of CardiP
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Trial, Invited talk and oral presentation during annual
meeting of Pakistan Endocrine Society, Islamabad. Nov
19, 2016; CardiP Trial: Cardiovascular Disease and
Diabetes: At AACE Symposium during summer retreat of
Pakistan Endocrine Society. May 29 -30, 2015. PC Bhurbon
, Pakistan; and Double trouble-Tackling Cardiovascular
risk in diabetic subjects: During Plenary session at 2nd
Annual Symposium of South Asian Federation of
Endocrine Societies (SAFES) meeting in Dhaka,
Bangladesh. April 24, 2015.
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